Man Group PLC Johnson & Johnson Call Options Transaction History

Man Group PLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$145.48 - $167.38 $5.76 Million - $6.63 Million	39,600 Added 55.38%	111,100 $18 Million
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $2.18 Million - $2.38 Million	15,100 Added 26.77%	71,500 $10.5 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $1.04 Million - $1.09 Million	-6,700 Reduced 10.62%	56,400 $8.92 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $9.19 Million - $10 Million	63,100 New	63,100 $9.89 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $648,270 - $697,662	4,200 Added 2100.0%	4,400 $728,000
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $30,210 - $36,052	200 New	200 $31,000

4,270

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $400B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.